title: Shorter treatments for hepatitis C: another step forward?
authors.affiliation: The Blizard Institute, Queen Mary's University of London, London E1 2AT, UK. Electronic address: g.r.foster@qmul.ac.uk.
authors.forename: Graham R
authors.initials: GR
authors.lastname: Foster
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D005260:Female; D005449:Fluorenes / Q000627:therapeutic use*; D005663:Furans / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011804:Quinolines / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood*; D012254:Ribavirin / Q000627:therapeutic use*; D000069474:Sofosbuvir; D013876:Thiophenes / Q000627:therapeutic use*; D014542:Uridine Monophosphate / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D001562:Benzimidazoles; D005449:Fluorenes; D005663:Furans; C573362:GS-9451; C582393:GS-9669; D011804:Quinolines; D012367:RNA, Viral; D013876:Thiophenes; C586541:ledipasvir; D012254:Ribavirin; D014542:Uridine Monophosphate; D000069474:Sofosbuvir